https://orcid.org/0000-0002-4843-5295
References
- Yan K, Desai K, Gullapalli L, et al. Epidemiology of atypical hemolytic uremic syndrome: a systematic literature review. Clin Epidemiol. 2020;12:295–305.
- Zadura AF, Zipfel PF, Bokarewa MI, et al. Factor H autoantibodies and deletion of complement factor H-related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome. Arthritis Res Ther. 2012;14(4):R185.
- Moore I, Strain L, Pappworth I, et al. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010;115(2):379–387.
- Hofer J, Janecke AR, Zimmerhackl LB, et al. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome. CJASN. 2013;8(3):407–415.
- Valoti E, Alberti M, Iatropoulos P, et al. Rare functional variants in complement genes and anti-FH autoantibodies-associated aHUS. Front Immunol. 2019;10:853.
- Matsumoto T, Fan X, Ishikawa E, et al. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie university hospital: concentration of C3 p.I1157T mutation. Int J Hematol. 2014;100(5):437–442.
- Durey MA, Sinha A, Togarsimalemath SK, et al. Anti-complement-factor H-associated glomerulopathies. Nat Rev Nephrol. 2016;12(9):563–578.
- Puraswani M, Khandelwal P, Saini H, et al. Clinical and immunological profile of anti-factor H antibody associated atypical hemolytic uremic syndrome: a nationwide database. Front Immunol. 2019;10:1282.
- Bresin E, Rurali E, Caprioli J, et al. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype. J Am Soc Nephrol. 2013;24(3):475–486.
- Heinen S, Jozsi M, Hartmann A, et al. Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. J Am Soc Nephrol. 2007;18(2):506–514.